Unmasking pustular psoriasis subsequent to COVID-19

Authors

  • Zeinab Mohseni Afshar Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Ronak Miladi Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran Array (unauthenticated)
  • Alireza Janbakhsh Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran. Array (unauthenticated)
  • Arefeh Babazadeh Infectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, I.R. Iran. Array (unauthenticated)
  • Zeinab Aryanian Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences,Tehran, Iran Array (unauthenticated)
  • Soheil Ebrahimpour Infectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, I.R. Iran. Array (unauthenticated)

DOI:

https://doi.org/10.66344/jpad.31.3.2021.1691

Abstract

The various cutaneous manifestations have recently appeared within context of 2019 novel coronavirus diseases (COVID-19). Currently, outbreaks of psoriasis were reported during COVID-19. We reported a case of a 32-year-old woman with COVID-19 who presented with pustular psoriasis. She was treated with oral prednisolone, hydroxyzine and topical clobetasol. The two-week follow-up revealed that her lesions were desquamating and that she was in a favorable situation. The current report will highlight specific skin manifestations of COVID-19, allowing clinicians to further confirm our suspicions.

 

Author Biographies

  • Ronak Miladi, Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran

     

     

  • Alireza Janbakhsh, Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran.

     

     

  • Arefeh Babazadeh, Infectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, I.R. Iran.

     

     

  • Zeinab Aryanian, Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences,Tehran, Iran

     

     

  • Soheil Ebrahimpour, Infectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, I.R. Iran.

     

     

Downloads

Published

10.04.2022

Issue

Vol. 31 No. 3 (2021): July - September

Section

Case Reports

License

Copyright (c) 2021 Zeinab Mohseni Afshar, Ronak Miladi, Alireza Janbakhsh, Arefeh Babazadeh, Zeinab Aryanian, Soheil Ebrahimpour

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Submission declaration

Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.

By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.

How to Cite

1.
Unmasking pustular psoriasis subsequent to COVID-19. J Pak Assoc Dermatol [Internet]. 2022 Apr. 10 [cited 2026 Jul. 25];31(3):526-9. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/1691